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The ubiquitin-proteasome system (UPS) is the main pathway responsible for the
degradation of misfolded proteins, and its dysregulation has been implicated in
several neurodegenerative diseases, including Alzheimer’s disease (AD). UBB+1, a
mutant variant of ubiquitin B, was found to accumulate in neurons of AD patients
and it has been linked to UPS dysfunction and neuronal death. Using the yeast
Saccharomyces cerevisiae as a model system, we constitutively expressed UBB+1 to
evaluate its effects on proteasome function and cell death, particularly under conditions
of chronological aging. We showed that the expression of UBB+1 caused inhibition
of the three proteasomal proteolytic activities (caspase-like (β1), trypsin-like (β2) and
chymotrypsin-like (β5) activities) in yeast. Interestingly, this inhibition did not alter cell
viability of growing cells. Moreover, we showed that cells expressing UBB+1 at lower
level displayed an increased capacity to degrade induced misfolded proteins. When we
evaluated cells during chronological aging, UBB+1 expression at lower level, prevented
cells to accumulate reactive oxygen species (ROS) and avert apoptosis, dramatically
increasing yeast life span. Since proteasome inhibition by UBB+1 has previously been
shown to induce chaperone expression and thus protect against stress, we evaluated
our UBB+1 model under heat shock and oxidative stress. Higher expression of UBB+1
caused thermotolerance in yeast due to induction of chaperones, which occurred to a
lesser extent at lower expression level of UBB+1 (where we observed the phenotype of
extended life span). Altering UPS capacity by differential expression of UBB+1 protects
cells against several stresses during chronological aging. This system can be valuable
to study the effects of UBB+1 on misfolded proteins involved in neurodegeneration and
aging.
Keywords: UBB+1, proteasome, Alzheimer’s disease, aging, cell death, yeast
Abbreviations: AD, Alzheimer’s disease; AZE, L-azetidine-2-carboxylic acid; CLS, chronological life span; DHR123,
dihydrorhodamine 123; HSPs, heat shock proteins; PI, propidium iodide; PS, phosphatidylserine; ROS, reactive oxygen
species; TUNEL, terminal deoxynucleotidyl transferase dUTP nick end labeling; UPS, ubiquitin proteasome system.
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INTRODUCTION
The ubiquitin proteasome system (UPS) is the principal
proteolytic pathway that degrades proteins in a regulated
manner. Its substrates are targeted for degradation by ubiquitin,
a 76-amino-acid polypeptide that is covalently attached to
one or more lysine residues of cellular proteins in a process
called ubiquitylation. Protein ubiquitylation is mediated by
an enzymatic cascade consisting of ubiquitin activating (E1),
conjugating (E2) and ligating (E3) enzymes which generates a
polyubiquitin chain that functions as the degradation signal.
The ubiquitin-conjugated proteins are subsequently recognized
and degraded by the 26S proteasome to short peptides, while
reusable ubiquitin is released by deubiquitinating enzymes
(DUBs; Welchman et al., 2005).
The UPS is involved in a variety of cellular functions such
as intracellular signaling, regulation of cell cycle and induction
of apoptosis (Hershko and Ciechanover, 1998). Deficiencies in
either ubiquitin or proteasome, unless timely corrected, can
cause cellular dysfunction or death. An example that ubiquitin
itself can be a cause of UPS impairment is the aberrant ubiquitin
UBB+1. This mutant ubiquitin results from a dinucleotide
‘‘deletion’’ probably occurring during transcription near the 3’
mRNA end, at the first of three ubiquitin repeats of ubiquitin
B gene UBB (van Leeuwen et al., 1998a). This process, termed
molecular misreading (van Leeuwen et al., 2000), preferentially
occurs at sequence repeats like GAGAG with 1:105 frequency
in different cell types. The aberrant mRNA results in the
translation of UBB+1, which has a 20 amino acid C-terminal
extension, with the rest of the protein being identical to ubiquitin
(van Leeuwen et al., 1998b). Due to this modification, the
C-terminal glycine, which is essential for the role in conjugation
of substrates, is missing. Thus, UBB+1 cannot be conjugated to
targets, but itself is ubiquitylated at lysines 29 and 48 and further
degraded by the proteasome (Lam et al., 2000; Lindsten et al.,
2002). Although UBB+1 is successfully degraded under normal
conditions when its levels are very low in the cells (Lindsten
et al., 2002), it tends to accumulate specifically in affected cells in
several neurodegenerative diseases characterized by the presence
of misfolded proteins, such as Alzheimer’s disease (AD) and
Huntington’s disease (van Leeuwen et al., 1998b; de Pril et al.,
2004), as well as in some non-neuronal pathologies such as
liver pathologies (French et al., 2001; Wu et al., 2002) and
sporadic inclusion body myositis muscle fibers (Fratta et al.,
2004). Shabek et al. showed that the polyubiquitin chain on
UBB+1 increases its affinity for the proteasome, and because
UBB+1 cannot be efficiently degraded, it inhibits degradation of
other ubiquitin-dependent proteasome substrates (Shabek et al.,
2009). Moreover Krutauz et al. demonstrated that extended
ubiquitin variants affect the ubiquitin-dependent turnover by
inhibiting deubiquitination activity of proteasome associated
DUBs (Krutauz et al., 2014). Thus, when UBB+1 accumulates
to higher levels, under conditions where the capacity of UPS
is challenged, this can result in a positive feedback loop in
which the already compromised UPS is further inhibited due
to the accumulated UBB+1 (Verhoef et al., 2009). Hence, the
presence of UBB+1 in human tissue serves as a reporter for UPS
impairment (Fischer et al., 2003). Since elevated levels of UBB+1
inhibit the UPS (Lindsten et al., 2002; Hope et al., 2003), cells
can be driven to cell cycle arrest, neuritic beading, mitochondrial
stress and apoptosis (De Vrij et al., 2001; Lindsten et al., 2002;
Hope et al., 2003; Tan et al., 2007). Studies in HeLa cells and
cortex slice cultures expressing UBB+1 showed that there is a
dose-dependent shift in UBB+1 properties from UPS substrate
to UPS inhibitor with increasing expression levels (van Tijn et al.,
2007). In human neuroblastoma cells, induction of UBB+1 causes
proteasome inhibition as well as induction of heat shock proteins
(HSPs), the latter presumably promoting the observed resistance
to oxidative stress (Hope et al., 2003). Hence, in this model the
protective effect of HSPs is bigger than the deleterious inhibition
of proteasome by UBB+1.
UBB+1 transgenic mouse lines have been established with
post-natal neuronal expression of UBB+1 (Fischer et al., 2009).
These mice showed increased levels of ubiquitylated proteins in
the cortex, at least 20% decreased proteasome activity, expression
changes in proteins similar to the proteomic profiles of AD brain
as well as the deficit in contextual memory. The same mouse
line has been used in a study where in addition to UBB+1 also
expanded huntingtin constructs were expressed using a lentiviral
system (de Pril et al., 2010). This resulted in increased neuronal
inclusion formation demonstrating that UBB+1 transgenic mice
are more vulnerable to toxic protein accumulation. Similar
results were observed by Tank and True expressing a protein
analogous to UBB+1, Ubext, in baker’s yeast. They found out that
UBB+1 causes UPS impairment andmakes cells more susceptible
to toxic protein aggregates (Tank and True, 2009).
Although UBB+1 has been studied in several in vivo models,
the exact molecular mechanism for UBB+1-mediated UPS
dysfunction and its contribution to cell death in AD is still
unclear. Using a yeast model, Braun et al. (2015a,b) showed
that UBB+1 expressed from a high-copy vector under the
control of an inducible promoter leads to UPS impairment,
mitochondrial dysfunction and toxic impairment of the basic
amino acids synthesis. Yeast S. cerevisiae is a suitable model
for aging and cell death studies, including apoptosis and
necrosis, as well as for the study of protein quality control
mechanisms, which are key cellular processes involved in
neurodegeneration and are well conserved between yeast and
higher eukaryotes (Khurana and Lindquist, 2010). In this
study, we constitutively expressed UBB+1 at lower and higher
expression levels under different conditions, including those
of chronological aging. We aimed at modeling conditions that
would occur naturally in aging neurons and evaluated the
effects on proteasome function and cell death. We showed
that UBB+1 inhibited all three types of proteolytic subunits
of the proteasome. However the constitutive expression of
low level of UBB+1 increased cellular resistance to misfolded
proteins and moreover prevented cells from accumulating
reactive oxygen species (ROS) during aging, delayed cell death
and increased chronological life span (CLS). On the other hand
high UBB+1 expression besides causing proteasomal inhibition,
conferred resistance to heat shock stress in exponential
phase, and this did not affect cell survival under aging
conditions.
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MATERIALS AND METHODS
Plasmids and Strains
Plasmids and strains used and constructed in this study are listed
in Table 1. Plasmid p413TEF CEN (Mumberg et al., 1995) is a
centromeric plasmid (1–2 copies) that carries the marker genes
HIS3 and ampC, for maintenance and propagation in S. cerevisiae
and Escherichia coli, respectively (Figure 1B). This plasmid
has a multicloning site flanked by the constitutive promoter
of translation elongation factor 1α (TEF1) and cytochrome c
terminator (CYC1). The p423 TEF 2µ plasmid (Figure 1B)
shares the same features as p413 TEF CEN but it is a
high copy number plasmid, due to its episomal autonomous
origin of replication (Mumberg et al., 1995). To create the
p413TEF UBB+1 and p423TEF UBB+1 plasmids, human UBB+1
gene was synthesized by DNA2.0 Inc. with a yeast Kozak
sequence (Hamilton et al., 1987) at the 5’ end, and the UBB+1
codons were optimized for efficient expression in S. cerevisiae.
The synthetic gene coding was inserted into pJ204 plasmid
resulting in pJ204:28004-UBB+1. Then UBB+1 was subcloned
from pJ204:28004-UBB+1 into p413TEF CEN and p423TEF 2µ
plasmids. Constructed plasmids were purified and verified by
restriction analysis and sequencing (GATCBiotech AB, Sweden).
Eshcerichia coli DH5α strain (fhuA2∆ (argF-lacZ) U169
phoA glnV44 880∆ (lacZ)M15 gyrA96 recA1 relA1 endA1
thi-1 hsdR17; Inoue et al., 1990) was used for cloning. The
S. cerevisiae strains used in this study were derivatives of
haploid CEN.PK113-11C (MATa his3∆1 ura 3-52 MAL-8c
SUC2). S. cerevisiae CEN.PK 113-11C was transformed with
purified p413TEF CEN, p423TEF 2µ, p413TEF UBB+1 and
p423TEF UBB+1 by standard procedures (Gietz and Woods,
2002) to generate the strains Low_EP, High_EP, Low_UBB+1
and High_UBB+1, respectively (Table 1). Transformants were
selected on synthetic minimal medium lacking histidine
(SD-His−). The presence of UBB+1 gene in the resulting yeast
strains was verified by PCR (Fisher Scientific, Sweden).
For Atg1 deletion, the knockout cassette was constructed with
a PCR amplified KanMXmarker (from pUG6 plasmid) including
approximately 500 bp upstream and downstream of the Atg1
locus. The CEN.PK 113-11C strain was transformed with this
cassette. Correct integration in the genome was confirmed by
PCR (unpublished data).
Cultivation Medium and Growth Conditions
Unless otherwise indicated, strains were grown in synthetic
drop-out medium containing yeast nitrogen base without
aminoacids (Formedium, Hunstanton, England) and a complete
supplement amino acid mixture lacking histidine (SD-His−;
Formedium, England), with 2% glucose as carbon source. Strains
were grown on SD-His− plates for 2–3 days at 30◦C or in
liquid SD-His− medium (either in tube or shake flasks with a
1:5 medium/volume flask ratio) at 30◦C with 200 rpm shaking.
Initial innoculation of the liquid SD- His− medium was at
OD600 of 0.15. The growth was monitored by measuring OD600
every 90 min during the first 12 h and at different time points of
stationary phase.
All experiments were performed with samples from at
least two independent transformants, and in triplicate, unless
specified.
Verification of UBB+1 Gene Transcription
by RT-PCR
Strains Low_EP, High_EP, Low_UBB+1 and High_UBB+1 were
grown in SD- His− medium overnight. At OD600 ∼2.5, cells
were harvested and total RNA was extracted with the waterbath
method (Li et al., 2009). After verifying concentration and
quality of RNA samples, 1 µg of each RNA sample was
treated with RNase-free DNase I (Qiagen, Sweden) according
to the manufacturer’s instructions. First-strand cDNA synthesis
was performed with 1 µg of DNase treated RNA using
random hexamers and RevertAid H Minus M-MuLV Reverse
Transcriptase (Thermo Fisher Scientific, Sweden) according to
the manufacturer’s instructions. Subsequently, multiplex PCR
was carried out for UBB+1 and ACT1 genes using Phusion
High-Fidelity DNA polymerase (Thermo Fisher Scientific,
Sweden). Housekeeping gene ACT1 was used as a reference gene
to normalize RNA levels.
Verification of UBB+1 Translation by
Western Blot
Protein extraction for exponential phase cells was performed as
described previously (Chen and Petranovic, 2015). Five OD600
of cells were spun down and resuspended in 200 µl of lysis
buffer containing 50 mM HEPES (pH 7.5), 150 mM NaCl,
2.5 mM EDTA, 1% Triton X-100 with Complete Mini Protease
Inhibitor (Roche, Switzerland). Two-hundred microliter of glass
beads (MP Biomedicals, USA) was added to the lysis buffer,
then the cells were mechanically disrupted at 4◦C for 3 min on
the FastPrep homogenizer (MP Biomedicals, USA). Afterwards,
samples were centrifuged and the supernatant was collected as
lysate. BCA protein assay kit (Thermo Scientific, USA) was used
to measure protein concentrations in the lysate and 30 µg of
protein for each sample was loaded on a 4%–12% Bis-Tris gel
(Invitrogen, USA).
Protein extraction from stationary phase cells was done
according to Kushnirov (Kushnirov, 2000), in 50 µl reducing
ClearPAGETM LDS Sample Buffer (VWR international AB,
Sweden). Samples were heated for 10 min at 70◦C. About 10 µl
of protein extract (0.6 OD600) was loaded per lane of 4%–12%
Bis-Tris gel (Invitrogen, USA). After electrophoresis, proteins
were transferred onto 0.2 micron PVDF membrane (BioRad,
USA) using a semi-dry transfer system (Towbin et al., 1979;
Kyhse-Andersen, 1984). Monoclonal antibodies against UBB+1
(Ub+1 40B3, Santa Cruz Biotechnology, Sweden) and GAPDH
(Santa Cruz Biotechnology, Sweden) were used for Western blot.
Enhanced chemiluminescence signals were detected using the
ECL Prime reagent (GE Healthcare, USA) and the ChemiDoc
XRS imaging system (BioRad, USA).
Proteasome Activity Measurements
Luminescence activity measurements of the chymotrypsin-,
caspase- and trypsin-like proteolytic activities of 20S proteasome
Frontiers in Molecular Neuroscience | www.frontiersin.org 3 June 2018 | Volume 11 | Article 200
Muñoz-Arellano et al. UBB+1 Protects Yeast From Death
FIGURE 1 | Human UBB+1 expression in yeast S. cerevisiae. (A) Alignment of ubiquitin protein sequences from human (Ubiquitin B H.s.), yeast (Ubiquitin S.c.) and
UBB+1 codon optimized for expression in yeast. The UBB+1 protein sequence is depicted with the 20 amino acid C-terminal extension. (B) Schematic map of the
UBB+1 expression plasmids. HIS3 stands for histidine auxotrophic marker, CEN or 2µ is the origin of replication, TEF1 is the promoter sequence and CYC1 is the
terminator sequence. (C) RT-PCR verifies the transcription of UBB+1 in Low and High_UBB+1 strains. The controls carried empty plasmid (EP) without UBB+1 gene.
Housekeeping gene ACT1 was used as a reference gene. (D) Western blot analysis of UBB+1 expression from exponential growth cells, using the anti-ub+1
antibody. Expression of UBB+1 (12 kDa) is indicated by an arrow.
were performed using the Proteasome-GloTM Cell-Based Assay
from Promega according to the manufacturer’s instructions
(Promega Biotech, Sweden). The Proteasome-GloTMCell-Based
Reagents each contains a specific luminogenic proteasome
substrate in a buffer optimized for cell permeabilization,
proteasome activity and luciferase activity. The specific
proteasome can recognize and cleave luminogenic substrates,
resulting in a luminescent signal that is proportional to the
amount of proteasome activity in cultured cells. One-hundred
microliter of SD-His− medium containing defined numbers
of cells (20,000, 40,000 and 80,000) was mixed with 100 µl
of Cell-Based Reagent and incubated for 20 min at room
temperature. Luminescence was recorded using the FLUOstar
Galaxy plate reader from BMG Labtechnologies (Sweden).
Every sample was measured in duplicate on two independent
transformants and in three independent experiments.
In order to exclude that the detected signal resulted
from non-proteasome specific cleavage of the aminoluciferin
substrates, in a parallel experiment the samples were incubated
with the proteasome inhibitor epoxomicin for 1 h before
measurement. Since no significant luminescence was detected
in the presence of epoxomicin, the signals detected in the
TABLE 1 | Plasmids and strains used in this study.
Plasmids or strains Relevant genotype Reference
Plasmids
pJ204:28004-UBB+1 UBB+1 AmpR (bla) This work
p413TEF CEN CEN HIS3 PTEF1/TCYC1 AmpR (bla) Mumberg et al. (1995)
p423TEF 2µ 2µ HIS3 PTEF1/TCYC1 AmpR (bla) Mumberg et al. (1995)
p413TEF CEN UBB+1 CEN HIS3 PTEF1-UBB+1-TCYC1 AmpR (bla) This work
p423TEF 2µ UBB+1 2µ HIS3 PTEF1-UBB+1-TCYC1 AmpR (bla) This work
S. cerevisiae strains
CEN.PK113-11C MATa his3∆1 ura 3-52 MAL-8c SUC2 van Dijken et al. (2000)
Low_EP CEN.PK113-11C, p413TEF CEN This work
Low_UBB+1 CEN.PK113-11C, p413TEF CEN UBB+1 This work
High_EP CEN.PK113-11C, p423TEF 2µ This work
High_UBB+1 CEN.PK113-11C, p423TEF 2µ UBB+1 This work
atg1∆ CEN.PK113-11C ∆Atg1 This work
atg1∆_Low_UBB+1 CEN.PK113-11C ∆Atg1, p413TEF CEN UBB+1 This work
Escherichia coli
DH5α fhuA2∆ (argF-lacZ) U169 phoA glnV44 880∆ (lacZ)M15 Bryant (1988)
gyrA96 recA1 relA1 endA1 thi-1 hsdR17
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samples without epoxomicin were attributed to the activity of 20S
proteasome.
Cell Survival and Viability Assays
Strains were grown overnight in SD-His− medium. Cultures
were diluted to OD600 0.15 in 6 ml of SD-His− medium
and incubated until ∆OD600 ≈ 1.0. Samples were collected in
exponential phase or on days 3, 6, 9 and 14 (i.e., days after start of
incubation). For the spot-assay, cells were pelleted, resuspended
in water (to OD600 0.2) and diluted in 10-fold series (10−1, 10−2,
10−3). 4.5 µl of each suspension was spotted on SD-His− plates.
To assess the cell resistance to oxidative stress or heat
shock, cells were incubated for 4 h in liquid SD-His− medium
supplemented with hydrogen peroxide at a final concentration
of 20 mM (Sigma-Aldrich, Sweden) or incubated at 52◦C for
2 h. Cell survival was analyzed by spot-assay after 3–4 days of
incubation at 30◦C.
Yeast cell viability was determined by staining with the
fluorescent vital dye FUN-1 [2-chloro-4-(2,3-dihydro-3-methyl-
(benzo-1,3-thiazol-2-yl)-methylidene)-1-phenylquinolinium
iodide] (Life Technologies Europe BV, Sweden). Cells were
harvested, washed and suspended in 10 mM HEPES buffer
(2% glucose) with 15 µM FUN-1 and 25 µM Calcofluor White
M2R (Life Technologies Europe BV, Sweden). Cells were then
incubated at 30◦C for 30 min protected from light before
analysis by fluorescence microscopy using TL-DIC, FLUO-GFP,
FLUO-RFP and FLUO-A4 settings. Metabolically active cells are
able to transport and concentrate the dye in the vacuole where it
forms structures in the shape of red bars or rods. Metabolically
non-active cells give out a uniform glow, due to the non-specific
distribution of the dye.
Every sample was measured in duplicate on two independent
transformants and in three independent experiments.
Inducing Protein Misfolding With
L-Azetidine-2-Carboxylic Acid
L-azetidine-2-carboxylic acid (AZE, Aze or AZC) is a proline
analog, that is incorporated into the proteins during translation,
causing changes in protein conformation, and eventually
misfolding (Zagari et al., 1990). Cells were grown overnight in
SD-His− medium, diluted to OD600 0.15 in 6 ml and incubated
at 30◦C. At OD600 ≈ 1, AZE (Sigma-Aldrich, Sweden) was added
to the culture to a final concentration of 30 mM. After 3 h
of incubation, cells were pelleted and diluted to OD600 0.2 in
1 ml of water. Serial dilutions (10−1, 10−2, 10−3) were used
for spot-assays on SD-His− plates. Growth was recorded after
2–3 days of incubation at 30◦C.
For continuous treatment with AZE, cells were collected and
diluted as before and spotted on SD-His− plates containing
2, 4 and 7 mM AZE, respectively. Growth was recorded after
2–3 days of incubation at 30◦C.
The viability was also measured by colony forming units
(CFU). Cells were serially diluted in SD-His− medium to
4 × 103 cells/ml. One-hundred microliter of diluted cells was
plated on SD-His− plates, which were incubated at 30◦C for
2–4 days. Viability of control strains was considered to be the
initial survival (100%). Every sample was measured in duplicate
on two independent transformants and in three independent
experiments.
Assessing the Apoptotic Markers
The production of ROS was measured using dihydrorhodamine
123 (DHR123, Sigma-Aldrich, Sweden). Cells were collected at
selected time points, washed and suspended in 50 mM sodium
citrate buffer with (pH 5.0) 50 µM of DHR 123 and then
incubated for 20 min at room temperature before analysis by
fluorescent microscopy using YFP settings. Cells showing an
intense fluorescence were treated as ROS accumulating cells.
Cell membrane integrity was assessed by detecting loss of
membrane asymmetry by exposed phosphatidylserine (PS), using
Annexin V labeling (Life Technologies Europe BV, Sweden) and
assessing membrane rupture by using propidium iodide (PI, Life
Technologies Europe BV, Sweden). Cells were washed in sorbitol
buffer (sorbitol 1.2 M, KH2PO4 35 mM and MgCl2 0.5 mM
pH 6.8) and digested with 120 U/ml lyticase (Sigma-Aldrich,
Sweden) for 2 h at 28◦C (Madeo et al., 1997; Herker et al., 2004).
After the incubation, cells were harvested by centrifugation
(5000 rpm, 1 min), washed twice with 1 ml of cold PBS buffer
(137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4 and 1.76 mM
KH2PO4, pH 7.4) and resuspended in Annexin-binding buffer
(Life Technologies Europe BV, Sweden). Finally, 3 µl of Alexa
Fluor 488 Annexin V and 1 µl of PI (100 µg/ml) were added
to 100 µl of cell suspension and then incubated for 15 min
at room temperature, protected from light. Finally the cells
were centrifuged (5000 rpm, 1 min) and resuspended in 20 µl
of Annexin-binding buffer for examination and analysis using
a fluorescence microscope with FLUO-GFP and FLUO-RFP
settings. Cells showing green fluorescence are apoptotic cells
(PS externalization-positive), cells showing red fluorescence are
necrotic cells (PI-positive) and cells showing fluorescence with
both filters, are late apoptotic cells.
To analyze DNA breakage, terminal deoxynucleotidyl
transferase dUTP nick end labeling (TUNEL) assay was
performed using the in situ Cell Death Detection kit (Roche AB,
Sweden), as described previously (Madeo et al., 1999). Yeast cells
were washed with PBS buffer, fixed with 3.7% formaldehyde and
digested with 120 U/ml of lyticase for 40 min at 30◦C. The cells
were then harvested, washed with SPM buffer (sorbitol 1.2 M,
KH2PO4 50 mM and MgCl2 1 mM pH 7.3) and transferred to a
polylysine-coated slide. The slides were rinsed three times with
PBS and incubated with permeabilization solution (0.1% sodium
citrate, 0.1% Triton X-100) for 2 min at 4◦C. After rinsing twice
with PBS, 50 µl of TUNEL reaction mixture was added to the
slide and incubated at 30◦C for 60 min. For co-staining with
DAPI (Life Technologies Europe BV, Sweden), 1 µl of DAPI
(1 mg/ml) was added 5 min before the incubation time ended.
Finally the slides were washed twice with PBS and mounting
medium was added to analyze by fluorescence microscopy with
FLUO-A4 and FLUO-GFP settings and DNA breakage could be
visualized as fluorescence.
In vivo detection of Caspase–like activity was done with
5 × 106 cells taken on 6, 9 and 14 days of incubation, which
were washed in PBS and resuspended in 200µl of PBS containing
10µMof a caspase substrate FITC-VAD-FMK (CaspACE FITC-
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VAD-FMK in situ marker, Promega Biotech, Sweden) and PI,
to identify cells with ruptured plasma membrane indicating
necrotic cell death, to a final concentration of 50 ng/ml.
After incubation for 20 min (protected from light) at room
temperature and with low agitation, cells were centrifuged
and washed twice with PBS. Finally cells were centrifuged and
resuspended in the remaining buffer. Stained cells were analyzed
by fluorescence microscopy with FLUO-GFP and FLUO-RFP
settings, and the bound marker is localized by fluorescence.
Fluorescence Microscopy
Images from stained cells were taken on an inverted Leica
AF 6000 fluorescence microscope (Wetzlar, Germany) with a
HCX PL APO CS 100.0x1.40 OIL objective, captured with a
DFC 360 FX camera, and analyzed with Leica Application Suite
software. Quantitative determinations involved the analysis of at
least 600 cells per sample from three independent experiments.
Brightness and gain settings were adjusted to avoid background
noise and discard false positives during the counting.
Real-Time PCR Analysis of Chaperone
Expression
UBB+1 expressing cells and control cells were grown in
liquid selective medium at 30◦C. Cell samples were taken on
exponential phase (OD600 of 1.0), days 1 and 3 of incubation.
Total RNA was extracted using the RNeasyr kit (QIAGEN,
Sweden) following manufacturer’s instructions. The synthesis
of first strand cDNA was performed using 1 µg of total
RNA and following the QuantiTec Reverse Transcription
(QIAGEN, Sweden) manufacturer’s protocol. The primers were
designed using the Primer3 software and synthesized by Sigma-
Aldrich Company (Sigma-Aldrich, Sweden). The DyNAmoTM
ColorFlash SYBRr Green qPCR Kit (Thermo Fisher Scientific,
Sweden) and the Mx3005P Agilent Technologies equipment
(Agilent Technologies, Sweden) were used for the QPCR assay.
DAL81 snd SPC10 were used as reference genes to normalize
the RNA levels. The relative transcription levels were calculated
using the ∆∆Ct method. Results are from three independent
experiments, performed duplicate per experiment. The data
analysis was performed using the MX pro QPCR software.
Statistical Analyses
Significance of differences observed between strains were
determined using two-tailed, student t-tests. Unless specified
explicitly, three independent replicates on two independent
transformants were analyzed. Values were represented as
mean ± SEM. P < 0.05 was considered to indicate significant
difference.
RESULTS
Expression of Human UBB+1 in Yeast S.
cerevisiae
The DNA sequence coding for the human UBB+1 protein was
codon-optimized for efficient expression in yeast S. cerevisiae.
In order to ensure the transcription and translation of the
correct mutated version, the GU nucleotides that are deleted
during spontaneous and random molecular misreading of the
native UBB gene in human cells, were omitted in the synthetic
version, giving rise to the mutated UBB+1 gene (Figure 1A and
Supplementary Figure S1). This UBB+1 gene was cloned into
either the single- (centromeric, CEN) or multi-copy (2µ) yeast
expression vectors, under the constitutive TEF1 promoter, giving
rise to p413TEF CEN UBB+1 and p423TEF 2µ UBB+1 plasmids,
respectively (Mumberg et al., 1995), enabling its constitutive
expression (Figure 1B). Yeast wild type strain CEN.PK 113-11C,
a host for heterologous protein production (van Dijken et al.,
2000), was transformed with the UBB+1 CEN or 2µ plasmids to
generate the Low_UBB+1 and High_UBB+1 strains, respectively.
Control strains (Low_EP and High_EP) were generated by
transforming CEN.PK 113-11C with the empty CEN or 2µ
plasmids (EP), without the UBB+1 gene. Transcription of UBB+1
was verified by RT-PCR (Figure 1C) and expression of UBB+1
protein was confirmed by Western blot (Figure 1D).
Expression of UBB+1 Reduces the
Proteolytic Activities of the 20S
Proteasome
It has been previously shown that overexpression of UBB+1
reduces the activity of the UPS in HeLa and human
neuroblastoma SH-SY5Y cell lines (Lindsten et al., 2002;
Verhoef et al., 2009). We measured the three proteolytic
activities of the 20S proteasome i.e., the caspase-like (β1),
trypsin-like (β2) and chymotrypsin-like (β5) proteases activities
in exponential Low_UBB+1 and High_UBB+1 strains, and
corresponding controls. To this purpose luminogenic peptide
substrates for the individual 20S proteolytic activities were used:
Z-norleucine-proline-norleucine-aspartate-aminoluciferin,
Z-leucine-arginine-arginine-aminoluciferin and Succinyl-
leucine-leucine-valine-tyrosine-aminoluciferin for the caspase-
like, trypsin-like and chymotrypsin-like activities, respectively.
We found that both low and high UBB+1 expression caused a
decrease in all three proteolytic activities of the proteasome
(p < 0.05) when compared with its respective controls
(Figures 2A–C). In the High_UBB+1 strain, the caspse-,
trypsin- and chymotrypsin-like activities decreased up to 32%,
10% and 35%, respectively. The activities of these three proteases
in Low_UBB+1 strain were reduced by 38%, 12% and 30%.
In order to evaluate the effects of a reduced proteasomal
activity on cell growth due to UBB+1 expression, UBB+1
and control strains were cultured in liquid SD-His− medium.
Cell growth was followed during exponential phase and cell
viability was measured in exponential and stationary phases by
spotting on SD-His− plates. Specific growth rate was determined
for each strain from the maximal slope on logarithmic scale
(µmax). Each experiment was conducted by triplicate on three
independent experiments. While low UBB+1 expression did
not affect exponential growth in liquid culture (µ = 0.39), the
High_UBB+1 strain had a significantly reduced growth rate
up to 16% (µ = 0.32) as compared to its control (µ = 0.38;
Figure 2D). Moreover, cells expressing UBB+1 at lower level
reached a higher cellular density after 1 day of incubation (OD600
Frontiers in Molecular Neuroscience | www.frontiersin.org 6 June 2018 | Volume 11 | Article 200
Muñoz-Arellano et al. UBB+1 Protects Yeast From Death
FIGURE 2 | UBB+1 inhibits the proteolytic activities of the 20S proteasome and affects exponential growth. The luminescent assays were performed individually to
measure the caspase-like, trypsin-like and chymotrypsin-like protease activities associated with the proteasome complex in cultured cells. Luminescence activity
measurements of the (A) caspase-, (B) trypsin-and (C) chymotrypsin-like proteolytic activities of the 20S proteasome are shown. The data shown are average values
of three independent experiments ± SEM. The asterisk (∗) indicates significant differences (p < 0.05). UBB+1 strains were compared with its respective controls
(Low_EP and High_EP). (D) The specific growth rate was determined from the maximal slope on logarithmic scale (µmax). The data represents an average of
three independent experiments from two different colonies for each strain. Low UBB+1 expression did not affect cell growth while high UBB+1 expression slightly
reduced growth rate (∗p < 0.05). Arrows indicated the time points when samples were taken for spot survival assay (E) of control strains (Low_EP and High_EP) and
UBB+1 expressing strains (Low_UBB+1 and High_UBB+1).
8.6 ± 0.2) as compared to controls (OD600 7.9 ± 0.3) and the
high_UBB+1 strain (OD600 7.5 ± 0.25; Figure 2D). From the
serial spot dilution assay, no difference on survival was observed
on exponentially growing cells and 1 day old stationary cells
expressing UBB+1 (Figure 2E).
Low UBB+1 Expression Increases Cellular
Tolerance to Chemically Induced Protein
Misfolding
We investigated how exponentially growing cells, with a
reduced proteasomal capacity, coped with misfolding burden,
by generating misfolded proteins using amino acid analogs. The
UPS is the main protein degradation pathway that eliminates
misfolded or damaged proteins and its dysfunction may lead
to protein accumulation, aggregation and neurodegeneration
in mouse brain neurons (Bedford et al., 2008). To test the
tolerance to protein misfolding stress, we challenged UBB+1
expressing cells with AZE. AZE is an analog of proline, whose
structural difference results in changes in torsion angles, the
direction of turns of the protein backbone, and cis-trans
isomerizations in the random newly synthesized polypeptides
that incorporate AZE instead of proline, inducing general
misfolding stress (Tsai et al., 1990; Baeza et al., 2008). We
incubated exponentially growing cells with 30 mM AZE for 3 h,
then cells were diluted and spotted on standard plates. After
3 days of incubation, we observed that all strains were affected
and no significant difference in survival was observed between
UBB+1 strains and controls (Figure 3A). The number of viable
cells was determined using CFU, which showed similar results
to spot assay (Supplementary Figure S2A). We also observed a
decreased viability in high_UBB+1 strain compared to its control
strain (Supplementary Figure S2A).
A second experiment was conducted where cells were
grown in liquid medium and spotted on plates containing
different concentrations of AZE. Interestingly, the Low_UBB+1
strain showed better survival, as compared to controls and
High_UBB+1 strain (Figure 3B and Supplementary Figure
S2B). The expression of UBB+1 protein was also confirmed by
Western blot during different concentrations of AZE treatment
(Supplementary Figure S3). This shows that low UBB+1
expression, although inhibited the core proteolytical activities of
the proteasome during exponential growth, increases the cellular
capacity to cope with misfolded proteins during a prolonged
misfolding stress.
Low UBB+1 Expression Prolongs CLS of
S. cerevisiae
Successful handling of misfolded proteins declines with age
which thus contributes to protein accumulation and aggregation,
a common feature of neurodegenerative diseases (Basaiawmoit
and Rattan, 2010). We tested whether Low_UBB+1 cells could
deal more efficiently with aging stress conditions. To evaluate
the effect of UBB+1 expression during aging, cells were grown
in liquid SD-His− medium. Sampling was conducted in the
exponential phase (OD600 of 1.0), and on days 3, 6, 9 and 14, after
the inoculation (Figure 4A). Cell viability was assessed by taking
identical amounts of cells (OD600 0.2) to make serial dilutions
and spot onto SD-His− plates.
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FIGURE 3 | Low UBB+1 expression increases cellular tolerance to misfolded proteins. Spot tests to analyze the effect of chemically induced protein misfolding on
survival of UBB+1 expressing strains and control strains. (A) Exponential cells, incubated for 3 h with 30 mM L-azetidine-2-carboxylic acid (AZE), were 10-fold serial
diluted and spotted on selective plates. The control cultures were left untreated. (B) Exponential cells were spotted in 10-fold serial dilutions on plates containing
2 mM, 4 mM and 7 mM of AZE, respectively. Every sample was measured in duplicate on two independent transformants and in three independent experiments.
We found that Low_UBB+1 strain was much more viable
after 14 days, when compared to controls and the High_UBB+1
strain (Figure 4B). This was supported by FUN1 staining,
which is a vital dye that passively diffuses into the cytoplasm
and gives a diffused green fluorescence. In the living cells
the dye is transported to the vacuole where it creates
compact foci with a striking red fluorescence, thus reducing
the diffuse green cytoplasmic fluorescence. Formation of the
fluorescent red cylindrical intravacuolar structures (CIVS)
requires both plasma membrane integrity and metabolic
activity. Controls and cells expressing UBB+1 at higher level
showed a similar reduction in viability (p < 0.05) from day
9 as compared to the Low_UBB+1 strain (Figure 4C). The
average viability for the Low_UBB+1 strain at day 14 was
above 70%, while cells expressing higher level of UBB+1 and
controls had the average viability below 10% (Figure 4C).
During CLS, the expression of UBB+1 protein was confirmed
by Western blot on day 3 and day 9 (Supplementary
Figure S4).
UBB+1 Prevents the Accumulation of ROS
and Decreases Apoptotic and Necrotic
Cell Death During Chronological Aging
Deficiencies in either ubiquitin or proteasome can lead to
the accumulation and aggregation of misfolded proteins with
lethal consequences. It has been reported that proteasomal
inhibition by UBB+1 overexpression contributes to proteotoxic
stress, neuritic beading of mitochondria (Tan et al., 2007),
cellular dysfunction and apoptotic cell death in HeLa and
SH-SY5Y neuroblastoma cells (de Pril et al., 2004). In order to
investigate the implications of UBB+1 expression in oxidative
stress and cellular death, we measured the levels of intracellular
ROS by using DHR123, where the nonfluorescent DHR is
FIGURE 4 | Low UBB+1 expression prolongs the CLS of S. cerevisiae. (A) Effect of UBB+1 expression on cell growth during chronological aging. All strains
maintained similar biomass during stationary phase. Sampling for further analyses was performed at the indicated time points (black arrows). (B) Spot tests of
Low_UBB+1, High_UBB+1 and control strains to investigate long time survival. 0.2 OD600 of cells were diluted in 10-fold series (10−1, 10−2, 10−3) and spotted on
selective plates from the indicated days. (C) Percentage of cell viability was determined by FUN1 staining. Above 70% of the cells expressing Low_UBB+1 remained
viable after 14 days of incubation. Representative images of metabolically viable cells and non-viable cells stained with FUN1 are shown. Viable cells showed
concentrated red staining in vacuole while non-viable cells showed uniform red glow. Samples were measured in duplicate on two independent transformants and in
three independent experiments.
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converted to the fluorescent product rhodamine 123 by the
interaction with superoxides. ROS accumulated at very low
levels during the first 6 days of incubation in all strains
(between 11% and 13%; Figure 5A). As expected, controls
showed an increased accumulation of ROS after 9 days of
incubation since the generation of ROS is the first apoptotic
trigger during chronological aging of yeast (Herker et al.,
2004). Interestingly, a lower production of ROS was observed
in Low_UBB+1 strain where the generation and accumulation
of ROS were prevented after 9 and 14 days of incubation
(Figure 5A).
Since ROS are the major inducers of apoptosis, we
investigated whether lower ROS observed in the Low_UBB+1
strain correlated with reduced cell death. We focused on
PS externalization, DNA fragmentation and the activation of
caspase, as the markers of cell death. PS is actively maintained
on the inner leaflet of the plasma membrane. In apoptotic
cells externalization of the PS indicates the loss of plasma
membrane asymmetry, which can be detected on the surface
of the cell by Annexin V staining. After 9 days in culture,
17% of control cells and 16% of high UBB+1 expressing cells
were positive in the Annexin V test, while only 8% of cells
expressing low UBB+1 showed fluorescence (Figure 5B). After
14 days, the difference between strains was less prominent
(Figure 5B).
DNA fragmentation is identified by the TUNEL assay,
which is used for labeling DNA nick-ends (both single- and
double-strand DNA breaks). In exponential phase and during
FIGURE 5 | UBB+1 expression decreases cell death during chronological aging. (A) UBB+1 expressing cells and controls were stained with DHR 123 to determine
the percentage of reactive oxygen species (ROS)-positive cells at different time points. Compared to control strain, low UBB+1 expression prevented cells to
accumulate ROS at day 9 and day 14 (∗p < 0.05). Representative images of DHR 123 stained cells from day 14 are shown. Cells showing an intense yellow
fluorescence were counted as ROS accumulating cells. (B) Annexin V and (C) TUNEL assays were performed in UBB+1 expressing cells and controls to determine
the percentages of cells exhibing phosphatidylserine (PS) externalization and DNA fragmentation after 9 and 14 days of incubation. UBB+1 expression, particularly at
low levels, reduced the ocurrence of these apoptotic markers as compared to its control strain. (D) Stained cells with FITC-VAD-FMK and propidium iodide (PI) to
determine the caspase-like activity and membrane integrity. Low levels of UBB+1 delays apoptosis on aged cells. After 14 days of incubation, controls showed a
greater portion of cells in secondary necrotic stage or cells already dead as compared to low UBB+1 expressing cells, whose membrane integrity remains intact. The
data shown were representative of average values ± SEM, of three independent experiments.
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first 6 days of incubation, all strains were negative in the
TUNEL assay. After 9 days of incubation, 7%–8% of cells
expressing UBB+1 showed fragmented DNA while slightly more
cells (12%–18%) were positive in controls (Figure 5C). After
14 days of incubation, substantially more cells in controls
exhibited DNA fragmentation (49%–56%) while 37% of cells
expressing UBB+1 at high level were TUNEL positive, and
43% of UBB+1 at low expression displayed fragmented DNA
(Figure 5C).
We finally measured the activation of caspases. In yeast,
caspase-like activity contributes to apoptotic cell death under a
variety of stimuli (Madeo et al., 2002, 2004), although caspase-
independent apoptotic pathways have also been identified (Liang
et al., 2008). It has been demonstrated previously, in human
mononuclear cells from peripheral-blood that apoptotic cell
death resulting from proteasome inhibition requires caspase
activation in most cases (Pérez-Galán et al., 2006). To evaluate
whether UBB+1 expression has an effect on caspase activation,
we used FITC-VAD-FMK that can diffuse into the permeabilized
cells and bind to activated caspases, allowing its identification
by fluorescence microscopy. Co-staining with PI was performed
to identify cells with ruptured plasma membrane, indicating
necrotic cell death. Cells that are positive for the FITC-VAD-
FMK assay alone, are considered induced apoptosis. Those
that are positive in the PI assay are necrotic with ruptured
plasma membrane and those positive in both assays, are
late apoptotic. An increased number of cells showed caspase
activation after 9 days, 32%–34% for the controls and 23%
and 25% for Low_UBB+1 and High_UBB+1 strains, respectively
(Figure 5D).
On 14-days old cells, the major caspase activity was measured
in UBB+1 expressing cells (49% and 61% for low and high
UBB+1 expressing cells, respectively) as compared to their
respective controls (26% and 54%). However, co-staining with PI
FIGURE 6 | High UBB+1 expression increases yeast resistance to heat shock. (A) Spot assay of UBB+1 strains and control strains after heat shocked at 52◦C for
2 h. Compared to other strains, high UBB+1 expression increased cell resistance to heat shock. (B) qPCR analysis of chaperone transcripts in low and high UBB+1
expression strains from exponential phase, day 1 and day 3. Both low and high levels of UBB+1 expression significantly increased the transcript levels of Ydj1, Ssd1
and Ssa1 genes in exponential phase and day 1. Comparing to Low_UBB+1 strain, the transcription levels of Ydj1 and Ssd1 were significantly higher in High_UBB+1
strain. The levels of these chaperone transcripts were significantly decreased after 3 days. (C) Viability of stationary cells exposed to 20 mM H2O2. Both of low and
high UBB+1 expression increased cell resistance to oxidative stress. Results are average values ± SEM of biological triplicates. The asterisk (∗) indicates significant
differeces (p < 0.05).
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revealed that a large portion of control cells (17%–55%) stained
for both FITC-VAD-FMK and PI while only 5%–7% of cells
expressing UBB+1 were actually dead (Figure 5D). Additionally,
and in accordance to our previous results on survival assay,
a significant portion of cells expressing low level of UBB+1
remained unstained (46%) on day 14 (Figure 5D), demonstrating
a beneficial effect on longevity.
High UBB+1 Expression Increases
Resistance to Heat Shock and Oxidative
Stress
A previous work in human neuroblastoma cells has reported
the induction of heat-shock proteins caused by expression of
UBB+1, which also promotes resistance to oxidative stress (Hope
et al., 2003). In yeast cells, proteasomal inhibition confers
thermotolerance due to the induction of chaperone expression
and trehalose accumulation (Lee and Goldberg, 1998). We
measured trehalose content in different strains under stress and
control conditions and did not find significant differences (data
not shown). We evaluated whether the proteasomal inhibition
caused by UBB+1 induced a heat shock response protecting
cells from stress. We evaluated the thermotolerance of UBB+1
expressing cells, in exponential phase (6 h) and on days 1, 6 and
9, respetively, by incubation of the liquid culture at 52◦C for 2 h.
0.2 OD600 of cells were sampled, serially diluted and spotted on
SD-His− plates. After 3 days of incubation at 30◦C, we observed
that stationary cells (1, 6 and 9-days old cells) expressing UBB+1
at higher level were able to tolerate better to the heat stress,
compared to controls and Low_UBB+1 cells (Figure 6A).
The transcription of chaperone genes (Ydj1-Hsp40, Ssa1-
Hsp70, Ssd1 and Hsp104) relevant for yeast thermotolerance
was measured by real-time PCR. The trancription levels
were compared between the UBB+1 expressing cells and its
corresponding controls from samples taken from exponential
phase (6 h), day 1 and 3, respectively. We observed that both low
and high levels of UBB+1 expression significantly increased the
transcript levels ofYdj1, Ssd1 and Ssa1 genes in exponential phase
and day 1 (p < 0.05). Moreover, the transcription levels of Ydj1
and Ssd1 were significantly higher in the high UBB+1 expression
strain, compared to low UBB+1 expresssion strain (p < 0.05).
Interestingly, the levels of these chaperone transcripts were
significantly decreased after 3 days (p < 0.05) and this was more
pronounced in the low UBB+1 expressing strain (Figure 6B).
Since the induction of chaperones promoted resistance to
oxidative stress, we exposed stationary cells (3, 6 and 8 days-old)
to 20mMH2O2. Better coping with oxidative stress was observed
in both Low_UBB+1 and High_UBB+1 strains as compared to
controls, particularly in aging cells (Figure 6C). There was no
significant difference in exponentially growing cells (data not
shown).
Low UBB+1 Expression Increases
Resistance to Misfolded Proteins in
Autophagy Defective Cells
The UPS and autophagy machinery are two major protein
degradation systems in cells. Several studies have suggested
a functional cross-talk and it has been demonstrated that
inhibition of UPS by proteasome inhibitors can activate
autophagy. Autophagy induced by proteasome inhibition was
shown to be important for controlling endoplasmic reticulum
stress and reducing cell death in cancer cells (Ding et al.,
2007). We tested if the autophagosomal pathway contributed to
protect cells from toxicity under misfolding protein stress on
cells expressing low level of UBB+1, where proteasomal activity
was reduced. The Atg1 gene, required for autophagosome, was
deleted to generate cells defective in autophagy (unpublished
data). The atg1∆ cells expressing UBB+1 and controls were
grown in liquid medium and then diluted and spotted on
plates containing 2, 4 and 7 mM of AZE, respectively. We
observed a lower survival on cells defective in autophagy
(atg1∆) as compared to controls (Figure 7 and Supplementary
Figure S5). Surprisingly, the expression of low UBB+1 increased
the cellular capacity to cope with misfolded proteins on both
WT and atg1∆ background, in 2 mM and 4 mM AZE
(Figure 7). However, at the higher concentration of AZE
tested (7 mM) only the UBB+1 strain (without the Atg1
deletion) was able to thrive (Figure 7 and Supplementary
Figure S5). This suggests that the autophagosomal pathway
might be relevant for cell survival in some conditions but is not
crucial in exponentially growing cells, during prolonged general
misfolding stress induced by 4 mM AZE, when UBB+1 was
present.
FIGURE 7 | Exponentially growing Low UBB+1 expression resists to AZE-induced protein misfolding stress under autophagy defective background. Spot assay of
Low_EP, Low_UBB+1, atg1∆_Low_EP and atg1∆_Low_UBB+1 cells on different concentrations of AZE. The expression of UBB+1 increased the cellular capacity to
cope with misfolding protein stress in the absense of the autophagic pathway. Every sample was measured in duplicate on two independent transformants and in
three independent experiments.
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DISCUSSION
In this study we present a yeast UBB+1 model, with the ubiquitin
mutant expressed constitutively at two levels. We used this
system to explore the role of proteasome impairment and cell
death by UBB+1 accumulation. It has been documented that
the accumulation of UBB+1 protein is among hallmarks of
several neurodegenerative diseases, including AD and other
tauopathies (van Leeuwen et al., 1998b; Fischer et al., 2003).
Studies in neuron cells have shown that UBB+1 can be further
degraded by the proteasome, but it acts as a potent proteasomal
inhibitor when it accumulates at high concentrations (Lam
et al., 2000; Lindsten et al., 2002). Moreover, some reports
showed that the proteasome activity is decreased in AD,
reinforcing the idea that the accumulation of UBB+1 is
related to proteasomal dysfunction (Keller et al., 2000). By
measuring the proteolytic activities of the 20S proteasome in
our yeast model, we demonstrated that expression of UBB+1,
either at low or high levels, inhibited the caspase-, trypsin-
and chymotrypsin-like proteases (Figures 2A–C). Although
high UBB+1 expression caused a decrease in the growth rate
of dividing cells, it did not affect cell survival of dividing
cells, which reached similar biomass after 24 h in culture
(Figures 2D,E).
Since proteasome dysfunction can lead to protein
accumulation and aggregation with detrimental consequences,
we evaluated the cellular tolerance to misfolded proteins in
the presence of UBB+1. Surprisingly, low UBB+1 expression
increased the tolerance to misfolded proteins when cells were
challenged with AZE (Figure 3). Because neurodegenerative
diseases, including AD and Huntington’s disease, are age-related
disorders, we evaluated the effect of UBB+1 on chronologically
aged cells and we found that low UBB+1 expression could extend
yeast life span (Figure 4).
The impairment of proteosomal activity by UBB+1
overexpression has been shown to be detrimental to the
neuronal cell cultures leading to mitochondrial stress (Tan et al.,
2007) and triggering apoptosis (De Vrij et al., 2001). Based
on our results, the constitutive low expression of UBB+1 in
yeast decreased the levels of ROS (Figure 5A), which normally
accumulates during aging. Consequently, UBB+1 expression
caused a delay of apoptotic and necrotic cell death (Figure 5).
High and induced expression of UBB+1 was found in different
models to be toxic (Tank and True, 2009). Braun et al. showed
that when UBB+1 was expressed from a high-copy vector under
the control of an inducible promotor, the cytotoxicity (as shown
by CFU, oxidative stress) occurred in the stationary phase
(post-mitotic cells) and the toxic effects were observed 2 or
3 days after the induction (which was in exponential phase;
Braun et al., 2015a). In our work, the expression of UBB+1 was
constitutive which allowed the cells to adapt for example by
overexpressing chaperones hence providing some cytoprotective
functions. Our constitutive UBB+1 model seemed to produce
enough of UBB+1 to cause some proteasomal inhibition, and a
potentially protective response but not enough to be detrimental.
Hope et al. reported that in their human neuroblastoma cell
model UBB+1 causes proteasome inhibition and induces the
expression of HSPs, protecting cells against heat and oxidative
stress conditions (Hope et al., 2003). Similarly in yeast, the
exposure to proteasome inhibitors causes the expression of HSPs
and the accumulation of trehalose conferring thermotolerance
to S. cerevisiae (Lee and Goldberg, 1998). We demonstrated
that high UBB+1 expression induced the transcription of HSPs
in yeast and, in accordance to previous findings, increased
the tolerance to oxidative stress (Figure 6). The induction of
HSPs was observed in early time points (logarithmic phase
and day 1), suggesting its activation as an initial protective
mechanism to counteract with protein misfolding after stress.
The up-regulation of Hsp104 and Ydj1 upon proteasomal
inhibition and its involvement in increased resistance to high
temperature of yeast is well documented (Lee and Goldberg,
1998). Our data showed a greater up-regulation of HSPs
transcripts, particularly of Ydj1, in the presence of high levels
of UBB+1 and consequently an increased resistance to heat
shock in that strain (Figure 6B). Although trehalose has
been reported to accumulate upon proteasomal inhibition
having additive effects in causing thermotolerance, we did
not observe any difference in the cellular content of this
disaccharide upon UBB+1 expression (data not shown). Based
on our test with the Atg1 deletion mutant, we proposed that
autophagy is not a crucial pathway for UBB+1 mediated survival
during AZE-induced misfolding stress in exponentially growing
cells.
The cell resistance to several stresses such as protein
misfolding, oxidative stress and heat, induced by differential
expression of UBB+1, is most probably not just due to the
induction of chaperones or the autophagosomal pathway, but
also to the participation of other cytoprotective mechanisms.
In yeast cells (Tank and True, 2009) has shown that blocking
ubiquitination of Ubext (a protein analogous to UBB+1) or
weakening its interactions with other ubiquitin-processing
proteins reduces the UPS impairment. Therefore, the interaction
of Ubext with more than one protein is crucial to elicit
impairment of the UPS (Tank and True, 2009). Another study
showed that the accumulation of UBB+1 may be due to the
inefficient hydrolysis of the C-terminus of UBB+1 by the
UCHL3 under oxidative stress in AD (Dennissen et al., 2011).
UBB+1 has been implicated to mediate neurodegeneration via
interaction with other components of the UPS (Ko et al., 2010).
The UBB+1 can serve as an inhibitor of DUB by binding to the
Ubp6, the primary enzymes responsible for the disassembly of
Lys48 linkages at proteasome (Krutauz et al., 2014). The UBB+1
can also be ubiquitylated by unusual ubiquitin-conjugating
enzyme E2-25K and E3 ligating enzyme TRIP12 and HUWE1.
The interation between E2-25K and UBB+1 is critical for
the accumulation of UBB+1-anchored polyubiquitin, which
results in proteasome inhibition and cell death (Ko et al.,
2010).
We proposed that our UBB+1 yeast model might benefit
to elucidate the contribution of different factors that together
with UBB+1 may contribute to the disease initiation and/or
progression (Supplementary Figure S6). Conservation of
cellular protein quality control systems between yeast and
human cells, makes yeast a useful model to study misfolding
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diseases. Humanized yeast models have been exploited to
investigate pathological proteins and pathways for example,
in Huntington’s disease (Giorgini et al., 2005), Parkinson’s
disease (Outeiro and Lindquist, 2003) and AD (Chen et al.,
2017). It is possible that the yeast discovery and validation
platforms will provide new knowledge and tools for the
identification of therapeutic strategies against neurodegenerative
or other misfolding diseases (Chung et al., 2013; Tardiff et al.,
2013).
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FIGURE S1 | Alignment of ubiquitin RNA sequences among human (Ubiquitin
B H.s.), yeast (Ubiquitin S.c.) and UBB+1 codon optimized for expression in
yeast.
FIGURE S2 | CFU measurement of cellular survival under different
concentrations of AZE treatment. (A) Exponential cells were incubated with
30 mM AZE for 3 h and plated on SD-His− plates. (B) Exponential cells were
plated on SD-His− plates containing 2 mM, 4 mM and 7 mM of AZE,
respectively. Results are average values ± SEM of biological triplicates.
FIGURE S3 | Western blot analysis of UBB+1 expression under different
concentrations of AZE treatment. GAPDH was used as a loading control.
FIGURE S4 | Western blot analysis of UBB+1 expression during CLS on day
3 and day 9. GAPDH was used as a loading control.
FIGURE S5 | CFU measurement of cellular survival under different
concentrations of AZE treatment. Exponential cells were plated on SD-His−
plates containing 2 mM, 4 mM and 7 mM of AZE, respectively. Results are
average values ± SEM of biological triplicates.
FIGURE S6 | (A) Construction of the strains using a one copy or multicopy
plasmid for the expression of the codon optimized UBB+1 sequence.
(B) Evaluation of the strains on exponential phase. (C) Evaluation of the strains
on stationary phase. Viability and the ocurrence of cell death markers were
measured at the indicated time points. (D) Evaluations of the strains under
stress conditions. Stress was induced either in liquid medium or on agar
plates. The percentages shown are the results by comparing the UBB+1
strains with their respective controls.
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